SANGAMO THERAPEUTICS, INC

SGMONasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$39.6M

▼ 31.6% YoY

Net Income

-$122.9M

▼ 25.5% YoY

EPS

$-0.44

▲ 10.2% YoY

Cash

$20.9M

▼ 50.0% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.